Delivery Order SPE2DB20D2014-SPE2DB23FC72Q
Award Date 7/13/23
Potential Completion Date 7/14/23
Potential Value $6.6K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,637 to Amerisourcebergen Drug Corporation to supply 30 tablets of 0.5 mg entecavir. The prime contractor, a subsidiary of Amerisourcebergen Corporation, will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania to fulfill requirements under the contract starting on September 13, 2023 through September 14, 2023. No set aside provisions or subcontracting arrangements...
- The Defense Logistics Agency awarded a $1,979.10 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 entecavir 0.5 mg tablets to be delivered to a location in Conshohocken, Pennsylvania within a one day period from September 7-8, 2023. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will serve as the prime contractor on this small business set-aside contract to supply pharmaceutical products in support of the Defense Logistics Agency's...
- The Defense Logistics Agency awarded a delivery order valued at $15,850.71 to AmerisourceBergen Drug Corp for the supply of Entecavir 0.5 mg tablets (30-count units) on a firm fixed price basis. The order, with a completion deadline of November 6, 2025, represents a non-competitive set-aside delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $1,810.25 contract is for the delivery of Entecavir 0.5 mg tablets to support DLA Troop Support Medical operations. Amerisourcebergen Drug Corp, through its Corporate Office division, has a history of providing pharmaceuticals and medical supplies to the Department of Defense under similar firm...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order for $3,286.83 from the Defense Logistics Agency (DLA) Troop Support Medical to supply 30 entecavir 0.5 mg tablets with a completion date of November 24, 2023. As the prime contractor, Amerisourcebergen Drug Corp will deliver the pharmaceutical products from its headquarters in Conshohocken, Pennsylvania in support of DLA's provision of medical supplies and medications to military treatment facilities. Amerisourcebergen...
- The Defense Logistics Agency awarded a $1,561.03 firm fixed price delivery order to AmerisourceBergen Drug Corp for Entecavir 0.5 mg tablets (30-count) on September 8, 2025, with completion scheduled for September 9, 2025. This is a non-set-aside competitive award issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical supply vehicle running through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a $5,786.46 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561579485 entecavir 0.5 mg tablets (30 count). The order is for pharmaceutical products to support the Department of Defense. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from July 24, 2023 to July 25, 2023. No set aside designation or subcontractors were identified. The Defense Logistics Agency manages...
- Amerisourcebergen Drug Corp has received a $1,801 firm fixed price delivery order from the Defense Logistics Agency to supply 30 entecavir 0.5 mg tablets by December 4, 2023. As the prime contractor, Amerisourcebergen Drug Corp will deliver the pharmaceutical products to support DLA Troop Support Medical facilities. A subsidiary of Amerisourcebergen Corporation, Amerisourcebergen Drug Corp provides pharmaceuticals and medical supplies through its Corporate Office division to various U.S....
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,532.79 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 4,564,150,864 units of the prescription medication Entecavir 0.5 mg tablets. This delivery order is a part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA. The IDC serves as the primary contract vehicle for...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Entecavir 0.5 mg tablets in quantities of 30 units, with a contract ceiling value of $4,809.12. This firm fixed-price delivery order, with an ultimate completion date of September 26, 2025, represents a non-competitive set-aside award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award falls under...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB23FC72QDelivery Order
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $6,557 to Amerisourcebergen Drug Corporation for 30 entecavir 0.5 mg tablets. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by July 14, 2023 in support of the Defense Logistics Agency's medical supply needs. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation. No subcontractors or set aside designations were identified in the award information.
Generated 12/15/23, 7:14 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.6k | 7/13/23 |